Megan Maroney, PharmD, BCPP, clinical associate professor, Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey; clinical psychiatric pharmacist, Monmouth Medical Center, Long Branch, NJ, discusses suicidal ideation and behavior, and depression, as potential adverse effects of some medications.
Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, discusses the role pharmacists play in the opioid crisis and pain management. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas.
Research presented at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas showed that patients who received focused attention from pharmacists during hospital stays expressed higher satisfaction.
The award is in recognition of members David F. Chen, senior director of the Section of Pharmacy Practice Leaders, and Verna L. Reed, director of Customer Relations and Materials Management for their exemplary work within the organization.
Krutika Mediwala, PharmD, BCPS, explains current best practices for health systems in antimicrobial stewardship. This video was filmed at the 2019 ASHP 54th Midyear Clinical Meeting & Exhibition in Las Vegas.
The consumption of these antibiotics may lead to dangerous unintended consequences, such as adverse effects that include treatment failures, and antibiotic drug resistance.
Volunteer leaders recognized for advancing mission of sections, new practitioners forum.
In addition to handling issues such as depression, post-traumatic stress disorder, suicide screenings, and anxiety, many mental health pharmacists deal with typical metabolic conditions, such as hypertension and diabetes.
Lisa Dumkow, PharmD, BCIDP, a clinical pharmacist of antimicrobial stewardship, discusses outpatient stewardship and why it's vital for health system pharmacists. This video was filmed at the 2019 ASHP Midyear Meeting Clinical Meeting & Exhibition in Las Vegas.
The US Department of Health and Human Services (HHS) has entered an agreement with Sanofi Pasteur to increase the company's domestic pandemic influenza vaccine production capabilities.
A pharmacy-driven assessment found more than half of patients with reported penicillin allergies were able to take antibiotics from the same drug class, rather than resorting to substitutes that may have downsides.
The award recognizes pharmacists who demonstrate leadership and innovation in enhancing patient care and other areas of pharmacy practice.
Formulary management tools can seem daunting or frustrating, but are ultimately effective ways to control costs without compromising clinical outcomes.
Population migration to more urban locales, and rural hospital closures are some factors increasing the challenges of health care access to patients and pharmacists in remote areas of the country. Innovation advocated by the National Rural Health Association (NRHA) may provide keys to improving access to health care services.
A novel, off-the-shelf bispecific antibody could serve as a new treatment option for patients with non-Hodgkin lymphoma who don’t respond to CAR T-cell therapy.
According to Janet Woodcock, MD and director of FDA’s Center for Drug Evaluation and Research, the agency is focused on the drugs used by Americans continuing to meet “strict quality standards.”
The educational sessions are available live and via simulcast.
The contrast agent is newly indicated to opacify the left ventricular chamber, and to improve the delineation of the left ventricular endocardial border in pediatric patients with suboptimal echocardiograms.
The approval was based on a phase 3 EDITION JUNIOR trial evaluating children and adolescents, aged 6 to 17 years, living with type 1 diabetes.
Managing elevated cholesterol is one of the the key elements to decreasing negative outcomes in atherosclerotic cardiovascular disease.
Consulting with some pharmacist moms and colleagues, these are the top tips for how they make the holidays more of a celebration and less of a logistical nightmare.
A patient at age 65 with high blood pressure could extend their life by more than a year with intensive treatment focused on a target systolic blood pressure of less than 120 mm Hg.
Under a new international collaboration, the FDA has granted supplemental approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic leukemia.
The Clinical Performance and Quality Measures included 6 performance measures, 6 process quality measures, and a new category of 10 structural quality measures for adults with high blood pressure.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Why is this woman in opioid withdrawal despite high dose methadone administration?
A newly-developed machine learning system may help act as an alert system for potential adverse effects from drug-drug interactions.
Cefiderocol (Fetroja, Shionogi) is indicated for adults with complicated urinary tract infections, including kidney infections caused by Gram-negative pathogens, who have limited or no alternative treatment options.
According to the affiliation agreement, the Institute for Safe Medication Practices will be an ECRI Institute subsidiary when the transaction closes in January, 2020.